Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)

Abstract Background Most pancreatic cancer patients present with advanced stage at diagnosis with extremely short expected survival and few treatment options. A multimodal palliative approach is necessary for symptom relief and optimisation of health-related quality of life. In a recent open-label t...

Full description

Bibliographic Details

Published in:	Trials
Main Authors:	Kathrin Wode, Johanna Hök Nordberg, Gunver S. Kienle, Nils O. Elander, Britt-Marie Bernhardson, Berit Sunde, Lena Sharp, Roger Henriksson, Per Fransson
Format:	Article
Language:	English
Published:	BMC 2020-09-01
Subjects:	Neoplasms Pancreatic neoplasms Mistletoe Complementary therapies Palliative care Quality of life
Online Access:	http://link.springer.com/article/10.1186/s13063-020-04581-y